Patient characteristics of new initiators of glycopyrronium bromide (GLY) – A multinational, multi-database real-world drug-utilization study

Katia MC Verhamme (Rotterdam, Netherlands), Katia M.C. Verhamme, Maria De Ridder, Lars Pedersen, Daniel Prieto-Alhambra, Francesco Lapi, Peter Rijnbeek, Rajeev K. Amar, Miriam Sturkenboom

Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Session: Novel avenues in the treatment of COPD I
Session type: Thematic Poster
Number: 4063
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Katia MC Verhamme (Rotterdam, Netherlands), Katia M.C. Verhamme, Maria De Ridder, Lars Pedersen, Daniel Prieto-Alhambra, Francesco Lapi, Peter Rijnbeek, Rajeev K. Amar, Miriam Sturkenboom. Patient characteristics of new initiators of glycopyrronium bromide (GLY) – A multinational, multi-database real-world drug-utilization study. Eur Respir J 2016; 48: Suppl. 60, 4063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS)
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Randomized, controlled study of the impact of a mobile health tool on asthma SABA use, control and adherence
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016

Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Is integrated disease management of COPD effective? Results of the RECODE cluster randomized controlled trial in real world patients
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014

An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Training tool versus instruction leaflet for pMDI use - A controlled group comparative study
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015

Cost-effectiveness of an integrated care program for COPD: The RECODE cluster randomized trial
Source: International Congress 2014 – Respiratory disease management in primary care
Year: 2014

Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT)
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Health status based treatment of COPD patients in primary care – A randomized controlled pilot study
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


LATE-BREAKING ABSTRACT: COPD healthcare research: Multicentre study on COPD out-patient healthcare in Germany (ORCAS)
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

TargetCOPD: A pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Is simulation based training in inhaler technique of health care professionals more effective than written information?: A randomised controlled study
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Applying telemonitoring (TMon) post-admission for COPD, at scale: Preliminary findings from a large European trial
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016


Mapping of COPD guideline adherence in primary care: An observational study in Belgium and Luxembourg
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013